Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers

NCT03232333 is registered in ClinicalTrials.gov with Miromatrix Medical Inc. as lead sponsor.

NCT NCT03232333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Lead sponsor
Miromatrix Medical Inc.
Phase
Observational
Overall status
Completed
Start date
July 21, 2017
Completion date
September 20, 2018
Enrollment
53 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer